Which agent has the brand name Actemra?

Prepare for the Dermatology Week 1 Exam with comprehensive study materials. Practice with detailed questions, flashcards, and expert explanations. Boost your knowledge and confidence for the exam!

Multiple Choice

Which agent has the brand name Actemra?

Explanation:
Actemra is the brand name for tocilizumab, a monoclonal antibody that blocks the interleukin-6 (IL-6) receptor, preventing IL-6 signaling in inflammatory pathways. This mechanism underpins its use in conditions like rheumatoid arthritis and other IL-6–mediated diseases. The other agents listed target different cytokines or receptors—anakinra blocks the IL-1 receptor, secukinumab inhibits IL-17A, and ustekinumab blocks IL-12/23—so Actemra specifically identifies tocilizumab.

Actemra is the brand name for tocilizumab, a monoclonal antibody that blocks the interleukin-6 (IL-6) receptor, preventing IL-6 signaling in inflammatory pathways. This mechanism underpins its use in conditions like rheumatoid arthritis and other IL-6–mediated diseases. The other agents listed target different cytokines or receptors—anakinra blocks the IL-1 receptor, secukinumab inhibits IL-17A, and ustekinumab blocks IL-12/23—so Actemra specifically identifies tocilizumab.

Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy